AskAt received a notice of allowance dated February 6, 2020 for a use patent of its EP4 receptor antagonist for the treatment of cartilage disease. The notice was issued in connection with Mexican Patent Application No. MX/a/2015/013328, from the Mexican Institute of Industrial Property (IMPI: Instituto Mexicano de la Propiedad Industrial).